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Figure 2 The vaccinia virus genome (www.micro.msb.le.ac.uk). 
Variability in poxvirus genomes is generally seen in the genome termini 
which encode non-essential genes that are not required for growth in tissue 
culture (Perkus et ai, 1991), whereas conserved genes that are essential for 
replication and other functions common to orthopoxviruses are centrally 
situated (Mackett & Archard, 1979). Non-essential genes also include those 
which encode proteins known as virokines (Kotwal & Moss, 1988a). 
Virokines, the first of which was discovered during the mapping of the 
vaccinia virus termini (Kotwal & Moss, 1988a) enhance viral replication and 
virulence by facilitating evasion of the host immune system (Smith & Kotwal, 
2002). 
Virokines 
These viral proteins bear structural as well as functional similarities to host 
proteins e.g. cytokines and cytokine receptors, chemokines and chemokine 
inhibitors and complement regulatory proteins (Smith & Kotwal, 2002). They 
are speculated to have been host-derived and structurally modified to be 
accommodated by the virus genome and to display increased potency (Smith 
& Kotwal, 2001). 
Cytokine and cytokine receptor homologs produced by the virus disrupt 
cytokine signalling and keep the infection 'hidden' from the host's immune 
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surrounding environment (Raven & .Iohnson, 1996). The energy status of 
tissues can be measured by their ATP content (Khan, 2003). 
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Figure 3 The structure of the energy molecule adenosine triphosphate (ATP) 
and its hydrolysis (www.people.virginia.edu/-rih9u/atpstruc.html) 
Energy is provided by the hydrolytic cleavage of the outermost phosphate 
group of an ATP molecule (see Figure 3) and the subsequent conversion of 
ATP to adenosine diphosphate (ADP) and an inorganic phosphate (Pi) 
(Raven & .Iohnson, 1996).The turnover of ATP within cells is very high as 
ATP is not a long-term storage form of energy, but is rapidly utilised and 
regenerated from ADP and Pi (Stryer, 1995). 
The Vaccinia Virus and ATP 
ATP is an essential component in vaccinia virus early gene transcription 
(Broyles & Moss, 1988; Gershowitz et ai, 1978). The high ATP level 
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Figure 4 An amino acid multiple sequence alignment of the N 1 L gene 
product in 4 different orthopoxviruses. Residues identical in all sequences 
are indicated by asterisks and conserved and semi-conserved sUbstitutions 
are indicated by colons and dots respectively. Due to its extensive 
attenuation, the Modified Vaccinia Ankara strain of vaccinia virus displays 
lesser amino acid sequence homology in the N 1 L gene (Billings et ai, 2004). 
3. Isolation and identification of genes from genomic DNA 
In order to characterise a single gene from a virus genome, it is necessary to 
amplify and isolate that gene and determine its nucleotide base sequence, 
which can then be compared to known sequences stored in a gene 
database. The techniques utilised to accomplish these are outlined in the 
sections to follow. 
3.1 The Polymerase Chain Reaction (PCR) 
Introduced in 1983 by Kary Mullis, this technique involves the use of two 
oligonucleotides known as primers, which are complementary to opposite 
strands of a selected stretch of DNA template, for the amplification of that 
selected region, wherein the product of one round of amplification becomes 
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Methods and materials 
1. Growth of vGK5 and Lister in Embryonated Hen's Eggs 
The vGK5 strain of vaccinia virus was obtained from Professor GJ Kotwal 
(project supervisor). The Lister SA vaccine vaccinia virus strain was obtained 
from Dr. Wolfie Katz. This smallpox vaccine is a freeze-dried preparation 
partially purified from sheep skin (8iovac Institute Pinelands, Cape Town) 
and was supplied at a concentration of 106 PFU/ml. Embryonated hens' eggs 
were obtained from the UCT Animal Unit (Mr. Noel Markgraaff). 
1.1 Viral inoculation 
Each egg was cleaned with 70% ethanol to avoid bacterial contamination. 
While examining each with an egg-candler, a pencil marking was made at the 
air sac and dorsal regions of each egg as illustrated in Figure 5. 
A 
--++---
B 
Figure 5 An embryonated hen's egg with markings for dorsal (A) and air sac 
(8) regions indicated (picture as used by Kotwal & Abrahams, 2004). 
Eggs were placed on an egg rack and an 'egg-pricker' was used to create a 
small opening at each marked region. A small drop of melted candle wax was 
placed above each dorsal opening. This would later serve to cover this 
opening to prevent bacterial contamination. A drop of 0.85% physiological 
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gradual freezing of cells as the temperature decreases at a rate of 1°C per 
minute thereby eliminating potential cell damage incurred by ice crystals or 
dehydration (www.research .umbc.edu/-jwolf/method5.htm).Alliquots were 
removed from the isopropanol and stored at -80°C until further use. 
To cultivate cells from frozen cultures, aliquots were thawed rapidly by hand, 
rnixed with 5 ml of MEM in a 15 ml falcon tube and centrifuged at 4°C for 5 
minutes at 100 x g in a Heraeus Multifuge benchtop centrifuge. Cells were 
sedimented at a low speed to prevent damage by compaction. The resulting 
supernatant containing the DMSO, which is toxic to growing cells, was 
discarded. Cells were gently resuspended in 5 ml of MEM (10% FCS, 1 % 
PSF) in a 25 cm2 culture flask and incubated at 37°C (5% CO2) overnight. 
Media was drawn off and replaced with 5ml of fresh MEM (10% FCS, 1 % 
PSF). Cells were grown to 100% confluency and maintained by passaging. 
1.3.2 Titration of vaccinia virus stocks 
BSC-1 cells were grown to 100% confluence in 2 ml of MEM (10% FCS, 1% 
PSF) per well of a 6-well plate. A volume of 1.5 ml of media was removed 
from each well and transferred to a sterile 15 ml falcon tube. The poxvirus 
stock was mixed with a vortexer to disrupt aggregated viral particles or 
sonicated for 20 seconds using a VirSonic Ultrasonic Cell Disruptor 100 at 
low voltage. A 1: 1 000 dilution of poxvirus preparation was made in fresh 
MEM and vortexed to mix. One microlitre of dilution was transferred to a well 
labelled with the corresponding dilution value i.e. 10-6, and mixed thoroughly 
by pipetting up and down. One hundred microlitres of this dilution was 
transferred to the adjacent well labelled with the corresponding dilution value 
i.e. 10-7 and mixed as described. Subsequent dilution steps were carried out 
in 3 of the remaining 4 wells to make 10-8 , 10-9 and 10-10 virus dilutions 
respectively. The final well was left virus free as a negative control. 
Cells were incubated at 37°C (5% CO2) for 2 hours to allow virus particles to 
infiltrate the cell monolayer. A volume of 1.5 ml of the previously removed 
media was added to each well and cells were incubated at 37°C (5% CO2) 
for 48hrs or until plaques were visible under the microscope. Media was 
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The viral genomic DNA was diluted in ddH20 and quantified using a Thermo 
Spectronic HeAios light spectrophotometer. DNA absorbance is read at a 
wavelength of 260 nm at which 1 OD (optical density) unit corresponds to 50 
micrograms/ml of double-stranded DNA (Sambrook & Russell, 200 1). The 
DNA was stored at -20°C for long-term storage. 
3. Amplification of the N1 L gene by the Polymerase Chain 
Reaction (PCR) 
3.1 Primer Design 
The Western Reserve (WR) N1 L gene sequence was obtained from 
http://www.ncbi .nlm.nih.gov/entrez (Entrez Nucleotide reference AF451287). 
Vaccinia virus strain WR N1 L gene: 
1 atgaggactc tacttattag atatattctt tggagaaatg acaacgatca aacctattat 
61 aatgatgatt ttaaaaagct tatgttgttg gatgaattgg tagatgacgg cgatgtatgt 
121 acattgatta agaacatgag aatgacgctg tccgacggtc cattgctaga tagattgaat 
181 caaccagtta ataatataga agacgctaag cgaatgatcg ctattagtgc caaagtggct 
241 agagacattg gtgaacgttc agaaattaga tgggaagagt cattcaccat actctttagg 
301 atgattgaaa catattttga tgatctaatg attgatctat atggtgaaaa ataa 
(Bartlett, N., Symons, J.A., Tscharke, D.C. and Smith, G.L.) 
The purpose of a PCR experiment can dictate the location of the primers to 
be used (Hyndman & Mitsuhashi, 2003), thus as the N 1 L gene needed to be 
cloned and sequenced, primers were designed to bind to the terminal regions 
of the sequence so as to amplify the entire gene. 
Forward primer (26mer): 
5' GAA TTC ATG AGG ACT CTA CTT ATT AG 3' 
31 
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The primer was designed to incorporate the first 20 bases at the 5' end of the 
WR N1 L gene sequence. An Eco RI restriction enzyme recognition site 
(highlighted bases) was added to the 5' end of the primer. 
Reverse primer (26mer): 
5' GCG GCC GCT TAT TIT TCA CCA TAT AG 3' 
The primer was designed to be 100% complementary to the last 20 bases at 
the 3' end of the WR N1 L gene. A Not I restriction enzyme recognition site 
(highlighted bases) was added to the 5' end of the primer. 
The 5' ends of primers can be modified to include restriction enzyme 
recognition sequences, which would then be incorporated into the amplified 
DNA product during PCR (Scharf, 1986). Eco RI and Not I restriction enzyme 
recognition sites were incorporated into the forward and reverse primer 
sequences respectively to allow for cloning of the amplified gene into a yeast 
cloning vectors cloning vector with identical restriction enzyme recognition 
sites (pPIC9), thereby providing the option of expressing the gene in yeast for 
future applications. 
Both primers were analysed by the Gene Runner computer software 
programme (www.generunner.com)forpotentialsecondarystructures.primer 
dimerisation events and Tm (melting temperature) values or temperatures at 
which 50% of the template DNA is hybridised (Hyndman & Mitsuhashi, 2003) 
according to the nucleotide base composition. Both were found to fit the 
criteria for a successful PCR. 
Primers were synthesized by the Oligo 100M DNA Synthesizer, Beckman 
Instruments Inc. 
3.2 PCR 
PCR was carried out on the purified Lister vaccinia virus genomic DNA with 
the use of designed primers (see section 3.1). Using the Roche peR Core Kit 
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(Version 3) according to manufacturer instructions, PCR reaction mixes for 
control and experimental reactions were set up and are outlined in Table 2, 
All reactions were set up on ice, 
Table 1 Control and experimental reaction mixes for PCR of the SA vaccine 
Lister vaccinia virus N 1 L gene 
Reagents: I Experimental Positive control Negative control 
(microlitre) (microlitre )' (microl itre) 
Viral DNA (240 
ng/microlitre) * 1 1 0 
10x peR Buffer 
(with 1,5 mM 5 5 5 
MgCI2) 
dNTP mix 1 (appr,O,2 mM) 1 1 
Forward primer 
(20 pmollmicrolitre) 2 11 2 
Reverse primer 
(20 pmol/microlitre) 2 1 2 
Taq polymerase 0,5 (1-5 Ul100 0,5 (1-5 Ul100 0,5 (1-5 Ul100 
microlitres) microlitres) microlitres) 
ddH20 (microlitre) 38.5 40,S 39.5 
*The concentration of template for the amplification of genomiC DNA should be between 100 
and 500ng (Grunenwald, 2003) II Primers for positive control obtained from Dr.Tayo 
Odunuga at concentration of 50pmol/ulfor amplification of VCP gene, 
The MgCI2 in the 10 x PCR buffer is an essential component to PCR, 
affecting both specificity and yield (Saiki, 1989), as it stimulates Taq 
polymerase activity (Gelfand, 1989). Mg2+ ions are quantitatively bound by 
dNTPs, thus the dNTP concentration is selected so as to leave sufficiently 
high levels of free MgCI2 (Saiki, 1989). 
The negative control allows one to determine the occurrence of 
contamination, a commonly encountered problem in PCR (Stirling, 2003), In 
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Table 3 Reaction mixes for ligation of SA vaccine Lister vaccinia virus N 1 L 
PCR DNA fragments and the pGEM-T Easy vector 
Experimental *Positive Background 
Reagent Mix control control 
(microlitre) (m icrolitre) (microlitre) 
Insert DNA 3 2 0 
pGEM-T Easy Vector 
(50 ng/microlitre) 1 1 1 
I T 4 DNA ligase 1 1 1 
(3 U/microlitre) 
2 x Rapid Ligation Buffer 5 5 5 
ddH20 0 1 3 
* Control insert DNA supplied at a concentration of 4 ng/microlitre. 
The amount of insert DNA should be equivalent to or more than that of vector 
DNA for successful ligation reactions (Perbal, 1988). Details of the pGEM-T 
Easy Vector are described in appendix. The T4 DNA ligase enzyme 
facilitates the formation of phosphodiester bond between 3' hydroxyl group 
and 5' phosphate of two dsDNA molecules and requires ATP (Perbal, 1988), 
which is provided by the 2 x Rapid Ligation Buffer (Promega). 
The positive control incorporates an insert which is known to produce 
successful ligation reactions and provides a means of confirming that 
reagents and ligation reactions are efficient, whereas the background control 
provides an indication of the prevalence of undigested or non-T tailed pGEM-
T Easy vector plasm ids which are in circular form and can thus be taken up 
by competent cells (Promega). To determine the outcome of control and 
experimental ligation reactions, a volume of each ligation reaction mix must 
be cloned into competent cells. 
4.3 Transformation 
The transformation procedure was carried out as according to the University 
of Cape Town BSc (Med) (Hon) techniques manual (2004) with modifications 
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4.4 Small-scale plasmid preparation 
The QIAprep Spin Miniprep Kit from Qiagen was used according to 
manufacturer instructions to purify the recombinant pGEM-T Easy vector 
DNA from cell culture. Reagent and protocol information was also obtained 
from 
http://mbclserver . rutgers . edu/Courses/1 M BB R04/31504 lab/31504 Lab3. pdf. 
Cells were pelleted by centrifugation Eppendorf Centrifuge 5415D in 1.5ml 
eppindorf tubes at 5 000 rpm for 5 minutes at room temperature. A volume of 
250 microlitres of Buffer P1 (50 mM glucose, 25 mM Tris-HCI pH 8, 10 mM 
EDTA pH 8 and 100 micrograms/ml RNase A) was used to thoroughly 
resuspended each cell pellet. An equal volume (250 microlitres) of lysis 
buffer, Buffer P2 (0.2 N NaOH, 1% SDS), was added and tubes were 
inverted 4 to 6 times to mix and incubated at r om temperature for a 
maximum of 5 minutes. 
A volume of 350 microlitres of Buffer N3 (3 M Guanidine-HCI pH 4.8) was 
added to neutralise each solution and tubes were once again inverted 4 to 6 
times to mix. Solutions became flocculent as cell debris and SDS were 
precipitated out. Tubes were centrifuged at 14 000 rpm for 10 minutes at 
room temperature to pellet precipitants. 
Supematants were transferred to spin columns and centrifuged at 14 000 
rpm for 1 minute to settle DNA in the column. Resulting flow-through was 
discarded and each column was washed with 750 microlitres of Buffer PE (10 
mM Tris-HCI pH 7, 50% ethanol) by centrifugation at 14 000 rpm for 1 
minute. The flow-through was discarded and the centrifugation step repeated 
to dry the column and remove any remaining ethanol which may interfere 
with future applications with the plasmid preparation. A volume of 50 
microlitres of elution Buffer EB (10 mM Tris-HCI pH 8.5) was directly 
dispensed onto the centre of each filter column. Columns were incubated at 
room temperature for 5 minutes for efficient DNA elution. Each column was 
transferred to a fresh 1.5 ml eppindorf tube and following a final 
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Figure 6 1 % Agarose gel of the Lister vaccinia virus N1 L gene PCR product. 
Lane (1) 1 kb DNA ladder MW Marker (Promega); (2) N1L gene peR product 
using 1 microlitres Lister genomic DNA template; (3) N1 L gene PCR product 
using 3 microlitres Lister genomic DNA template; (4) no sample loaded; (5) 
VCP gene peR product, internal positive control; (6) no template DNA, 
negative control. 
The Lister vaccinia virus N 1 L gene peR product was ligated into a cloning T-
vector using the pGEM-T Easy Vector system (Promega) and restriction 
enzyme digestion was used to confirm positive clones. Digested DNA 
products were visualised on a 1 % agarose gel (see Figure 7) by Ethidium 
Bromide (EtBr) staining. 
Plasmid digestion with the Eco RI restriction enzyme produced a DNA band 
corresponding to the size of the pGEM-T Easy plasmid vector (3 015 bp) (A) 
and a band less than 500 bp in size (8). This was expected as the Eco RI 
enzyme cuts on either side of the plasmid multiple cloning site, excising the 
DNA insert. The Pst I and Hin dill restriction enzymes, which have single cut 
sites in the vector and insert respectively, produced linearised fragments 
43 
Un
ive
rsi
ty 
of 
Ca
pe
 To
wn
which ran above the EcoR 1 digested plasmid confirming the presence of the 
an insert (see lanes 4 and 5 ). 
3530--
2027--
564--
1 2 3 4 5 
A 
B 
Figure 7 1 % Agarose gel of restriction enzyme digested plasmid 
preparations carrying the vaccinia virus N1 L gene from transformed XL Blue 
E.coli colonies. Lane (1) Lambda DNAlEcoR1 + Hind III Marker (Promega); 
(2) uncut plasmid preparation; (3) EcoR1 digested plasmid preparation; (4) 
Hin dill digested plasmid preparation and (5) Pst1 digested plasmid 
preparation. 
3. Sequencing of the Lister N1 L gene insert 
Electronic sequencing results were analysed using the Chromas software 
(www.technelysium.com.au/chromas.html) programme and entered into a 
gene database to compare its homology to genes of preciously sequenced 
genomes using the nucleotide-nucleotide BLASTn programme 
(www.ncbi.nlm.nih.gov/BLASTD. The SA vaccine Lister vaccinia virus was 
found to be 100% homologous to its corresponding gene in the Western 
Reserve (WR) vaccinia virus genome (Figure 8). 
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Figure 8 A multiple sequence alignment of the SA vaccine Lister and 
Western Reserve vaccinia virus N1 L genes 
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Introduction 
1. Detection of ATP Using Firefly Luciferase Bioluminescence 
To determine whether the vaccinia virus 13.8 kDa protein allows viral 
replication in the brain by altering brain ATP levels or utilisation, ATP levels in 
brain tissue infected with a vaccinia virus wild type and 13.8 kDa negative 
strain needed to be measured. When working with animal tissues, the use of 
a biochemical assay for adenosine 5' triphosphate (ATP) detection is 
generally preferred (Khan, 2003). The firefly luciferase bioluminescence 
system is one which is specific for ATP (Deluca & McElroy, 1978). 
luciferases are enzymes, which catalyse light generating reactions in 
bioluminescent organisms by the oxidation of a substrate known as luciferin 
(Sambrook & Russell, 2001) 
This bioluminescent detection system is based on the conversion of luciferin 
substrate to oxyluciferin (Kamidate, 1996) in the presence of ATP, 
magnesium ions and oxygen, and is accompanied by the emission of light at 
560 nm (see Figure 9) (Deluca & McElroy, 1978). The amount of light 
emitted is linearly related to the concentration of ATP present (Kamidate, 
1996). 
OXyludterm 
Figure 9 Bioluminescent reactions catalyzed by firefly luciferase 
(www.biotek.com/products/tech ). 
In the initial reaction, the luciferase enzyme forms a complex with the luciferin 
and adenosine monophosphate (AMP) from ATP and two inorganic 
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phosphates are released (lemasters & Hackenbrock, 1978). Magnesium 
ions are essential as magnesium-bound ATP is the actual substrate for 
activation of the luciferase enzyme (Deluca & McElroy, 1978). The enzyme 
complex then reacts with molecular oxygen resulting in the production of 
oxyluciferin, AMP, carbon dioxide (C02) and light (lemasters & 
Hackenbrock, 1978). The reaction takes place rapidly wherein light emittion 
occurs within milliseconds and a peak is reached after approximately 0.3 
seconds (Deluca & McElroy, 1974). The amount of light is measured by a 
luminometer in relative light units (RlU). 
Extraction of ATP from cells requires consideration of specific factors 
including effective cell lyses for the release of ATP, an extractant buffer 
which inactivates ATP converting enzymes (ATPases) and which does not 
interfere with the activity of the luciferase enzyme (Yang, 2002). 
Khan optimised the detection of ATP by firefly luciferase bioluminescence in 
mouse brain striata (Khan, 2003) by comparing different tissue homogenisers 
for the disruption of cells as well as different solutions for extracting. Optimal 
results were obtained when disrupting tissue with an Ultraturax homogeniser 
in the presence of 10% perchloric acid (Khan, 2003). Perchloric acid (HCI04 ) 
is a strong acid, which extracts ATP whilst inactivating ATPases (Yang, 
2002). 
The luciferase enzyme is subject to inhibition by anions such as HCI04 in 
perchloric acid (www.pathtech.com). however this interference can be 
minimised by acid neutralisation with potassium chloride (KOH) and 
appropriate sample dilution and a highly stable luminescence signal can be 
achieved (Khan, 2003). 
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transferred to a sterile 15 ml falcon tube and 200 microlitres of a 2.5M KOH 
(potassium hydroxide) solution was added to each aliquot This strong base 
neutralised the perchloric acid solution. The mixture became flocculent and 
was centrifuged at 4 500 rpm for 5 minutes at 4°C to pellet the precipitant 
The resulting supernatants were diluted 1 :40 in 0.1 M TE buffer pH 7.75 (100 
mM Tris; 2 mM EDT A). This pH is optimal for luciferase activity 
(INWW.pathtech .com). 
A volume of 100 microlitres of each diluted extract was loaded into wells of a 
sterile MultiScreen Opaque 96-well-plate (Millipore). Opaque plates prevent 
light carryover between adjacent wells and allow for rapid light measurement 
reading over a series of wells (Thorpe et ai, 1985). A volume of 100 
microlitres of each concentration of a dilution series of adenosine 5' 
triphosphate (ATP) disodium salt (Sigma-Aldrich) was loaded into respective 
wells and used for an ATP standard curve from which ATP content for 
experimental samples could be extrapolated. A volume of 100 microlitres of 
TE Buffer pH 7.75 was loaded in triplicate to obtain an average background 
ATP level reading. 
Using the Luminoskan Ascent (Amersham) or Veritas microplate luminometer 
(Turner Biosystems), an ATP measurement for each well was obtained in 
relative light units (RLU) following the addition of 50 microlitres of the 
ENLITEN rLuciferin/Luciferase reagent (Promega) by luminometer 
dispensers and a brief shaking step to allow mixing of reagents. The average 
background ATP level as determined from the RLU readings given for wells 
containing TE buffer pH 7.75 was subtracted from all other sample readings. 
A protein estimation using the BioRad protein estimation kit with bovine 
serum albumin (BSA) protein standards was performed on 50 microlitres of 
each mouse brain homogenate and used to correlate ATP concentration with 
average protein content per sample group. Protein content per sample was 
measured on an Anthos 2010 microplate reader (Separation Scientific). ATP 
concentrations for SA vaccine Lister vaccinia virus, recombinant vGK5 
vaccinia virus and mock-infected mouse brains at each 24 h period post-
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Results 
1. Vaccinia virus replication in mouse brain 
Mouse brains infected with 100 PFU of the Lister or vGK5 vaccinia virus were 
homogenised and their viral concentrations determined and compared 
following titration in BSC-1 cell cultures (Figure 10). Viral titres in vGK5 
vaccinia virus-infected mouse brains increased by 4 log over the period of 
infection. Lister vaccinia virus titres did not increase for the first 4 days of 
infection (200 PFU/ml). At 5 days post-infection these titres increased by a 
factor of 4 (800 PFU/ml). 
8 
E 6 
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48 72 96 
Time post-infection (hours) 
120 
• Lister 
. vGKs l 
Figure 10 Viral titres of Lister and vGK5 vaccinia virus-infected mouse brains 
over a 5 day infection period. 
2. ATP level analysis 
ATP levels in Lister vaccinia virus, recombinant vGK5 virus and mock-
infected mouse brain homogenates were determined using a 
luciferin/luciferase bioluminescence assay. Average ATP concentrations for 
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each sample group were calculated using the line equation obtained from 
the linear double log fitting of a standard curve (Santos et ai, 2003) of known 
ATP concentrations (see Figure 11) and results were graphically compared 
(Figure 12). 
y = 1.016X_+_1_S_.S_34 ___ S __ 
-15 -10 -5 o 
log10 ATP (moles) 
Figure 11 Linear double log fitting ATP standard curve 
An initial decrease in ATP was observed within the first 48 h of infection in 
both Lister and vGK5 vaccinia virus-infected groups, yet in contrast to the 
vGK5 virus and mock-infected mice, the ATP levels in Lister vaccinia virus-
infected brains were unchanged for the remainder of the period of infection 
(Figure 12A). The ATP concentrations in mock and vGK5 virus-infected 
mouse brains underwent small fluctuations during the intermediate stages of 
infection and eventually increased to concentrations above those seen at 24 
h post-infection (Figure 12A). A significant difference (p-value=0.01613) in 
ATP concentrations between wild type and knockout-infected mouse brains 
was obtained at 120 h post-infection (Figure 128), with no significant 
differences at prior stages of infection. 
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Figure 12A Line graph of ATP concentrations in Lister vaccinia virus, recombinant vGK5 vaccinia virus and mock-infected mouse 
brain over a 5 day infection period 
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Figure 128 Bar graph of ATP concentrations in Lister vaccinia virus, recombinant vGK5 vaccinia virus and mock-infected mouse 
brain over a 5 day infection period with standard deviations indicated by error bars per sample group and point of significant 
difference (*p-value = 0.01613) in ATP concentration shown. 
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pPIC9 Stu I 
8.0 kb 
Figure 13 The pPIC9 fusion vector (www.invitrogen.com). 
Once positive recombinant P.pastoris clones are identified and isolated, 
mass production of recombinant proteins is made possible by growth in 
appropriate yeast nutrient media and optimisation of methanol induction. 
Expressed protein can be concentrated by numerous methods including 
ammonium sulphate precipitation, filtration or centrifugation. 
2. Immunodetection of proteins expressed in P.pastoris 
Proteins can be identified on the basis of their size and antigenic properties 
by immunoblotting techniques e.g. western blotting (Rybicki & Purves, 1996; 
Towbin et ai, 1979) or slot-blotting. 
Proteins are first separated according to their size (Grierson, 1990) by 
Sodium Dodecyl Sulphate Polyacrylamide Gel Electrophoresis (SDS-PAGE). 
Polyacrylamide gels are formed by the polymerisation of acrylamide 
monomers and their covalent cross-linkage with N, N-methylene-bis-
acrylamide (Perbal, 1988) in the presence of a chemical catalyst (Grierson, 
1990). These acrylamide cross-links serve as pores through which proteins 
must pass (Sam brook & Russell, 2001). 
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BMGY and incubated for a further 48 h with shaking (200 rpm). The glycerol 
in BMGY is a carbon source which represses heterologous gene expression 
(Cereghino & Cregg, 2000). 
00600 readings were taken at regular intervals. At an 00600 reading between 
2 and 6, where 1 00 unit corresponds to approximately 5 x 107 cells/ml of 
culture (Invitrogen), cultures were centrifuged at 4 500 rpm in a Heraeus 
Multifuge 3 L-R benchtop centrifuge for 10 minutes at room temperature to 
pellet yeast cells. The supernatants were discarded and cell pellets were 
rinsed brie"lly in 2 washes of distilled water, resuspended in 0.5 volumes of 
BMMY (Buffered Methanol-complex Medium) (1 % yeast extract, 2% peptone, 
100 mM potassium phosphate pH 6.0, 1.34% yeast nitrogen base, 4 x 10-5% 
biotin, 0.5% methanol) and incubated at 30°C with shaking (200 rpm) for 24 
h. The methanol in this medium served to initiate the induction of 
recombinant protein expression. 
Both BMGY and BMMY contain phosphate buffer which has a very high 
buffering capacity and buffers over a range of pH values (Sam brook & 
Russell, 2001). The yeast extract and peptone in each medium helps to 
stabilise secreted proteins and limit their proteolysis whilst simultaneously 
feeding the culture (www.invitrogen.com). 
A filter-sterilised 100% methanol solution was added to each BMMY culture 
to a final concentration of 0.5% every 24 hours for a period of 96 hours. 
Methanol was added to compensate for loss due to consumption and 
evaporation (www.invitrogen.com). 
Yeast cultures were centrifuged at 4 500 rpm for 10 minutes and the resulting 
supernatants were further centrifuged at 10 000 rpm for 45 minutes in a 
RC5B Plus Sorvall centrifuge to sediment remaining cell debris. The 
supernatants were stored at 4°C for short-term storage or frozen at -20°C in 
an equal volume of 100% glycerol for long-term storage following filtration 
through a 0.22 um filter to remove any contaminating bacteria. Filtration was 
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A maximum volume of 15 ml of protein supernatant per centriprep sample 
container was concentrated at 3 000 x g in a Heraeus Multifuge benchtop 
centrifuge for 40 minutes to reduce the supernatant volume 5-fold. This was 
carried out at 4°C to prevent loss of proteins due to the instability of the 13.8 
kDa protein. The filtrate was decanted and retentate remaining in the sample 
container was centrifuged for an additional 10 minutes at 3000 x g to reduce 
the supernatant volume a further 3-fold. 
The concentrated P.pastoris expression supernatants were analysed by 
SDS-PAGE as previously described and compared to non-concentrated 
protein samples to determine differences in 13.8 kDa protein concentration 
and purity. 
3. Immunodetection of the 13.8kDa protein 
3.1 Slot Blotting 
An anti-rabbit polyclonal 13.8kDa antibody was obtained from the Kotwal lab 
in the USA and stored at -20°C. The Minifold II Slot-Blot System (Schleicher 
& Schuell) was used according to manufacturer instructions for the transfer of 
proteins onto a nitrocellulose membrane. 
c=====}---------- c::.J'-~ ~ ',',,,!, r'a'p 
Figure 14 Minifold II Slot-Blot System assemblage 
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Results 
1. Expression of the 13.8kDa protein in Pichia pastoris 
Ppastoris colonies transformed with a pPIC9 fusion vector carrying the 
Western Reserve N1 L gene were grown in nutrient media and recombinant 
protein expression was induced by the addition of methanol to 0.5% final 
concentration every 24 hours over a period of 96 hours. Pre- and post-
induction expression supernatants were resolved by SDS-PAGE and protein 
bands were visualised by Coomassie Brilliant Blue staining. 
35 kDa 
25 kDa 
15 kDa 
10 kDa 
1 2 3 4 5 6 7 8 
Figure 15 15% SDS-PAGE gel of Ppastoris yeast expression supernatants. 
Lane (1) Promega Broad Range Molecular Weight Marker; protein 
expression of 13.8 kDa protein (2) pre-induction; (3) 24 h post-induction in 
BMMY; (4) 24 h; (5) 48 h; (6) 72 h; (7) 96 h post-induction with methanol; (8) 
YM-10 Centriprep concentrated 
2. Immunodetection of the 13.8kDa protein 
Proteins contained in Ppastoris expression supernatants were immobilised 
onto nitrocellulose membranes by the slot or western blotting techniques and 
probed with an anti-rabbit primary antibody. Antibody complexes were 
detected using chemiluminescent detection techniques. 
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The 13.8 kDa antibody complex was detected in post-induction expression 
supernatants of the JL6 and JL4 P.pastoris recombinant clones by slot-blot 
analysis (see Figure 16). This complex was not detected in pre-induction 
samples. 
Figure 16 X-ray film of slot-blot of pre- and post-induction P.pastoris 
expressed proteins detected with the 13.8 kDa anti-rabbit primary antibody. 
Bands correspond to (1) JL6 pre-induction expression supernatant, (2) ..IL6 
expression induced with 1 % methanol, (3) retentate and (4) filtrate from 
concentration of JL6 expression supernatant in YM-10 Centriprep 
ultrafiltration centrifugal device, (5) JL4 pre-induction expression supernatant, 
(6) ..IL6 expression induced with 1 % methanol and (7) recombinant VCP 
(vaccinia virus complement control protein) expressed in P.pastoris (negative 
control). 
Figure 17 The vaccinia virus 13.8 kDa protein expressed in Ppastoris 
detected by Western blot analysis using polyclonal anti-rabbit 13.8 kDa 
primary antibody. 
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Appendix 1: The pGEM-T Easy Vector 
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Figure 15 The pGEM-T Easy cloning vector (www.promega.com). Thymidine 
(T) residues for the ligation of peR product adenine overhangs are indicated 
within the multiple cloning site. Ampicillin resistance (Ampr) marker as well as 
SP6 and T7 primer binding sites for sequencing of DNA inserts are indicated. 
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